# FDA 483_RESPONSE - Wedgewood Connect, LLC - November 17, 2023

Source: https://www.globalkeysolutions.net/records/483_response/wedgewood-connect-llc/f7331f63-966b-46c2-9139-d427f1e0e9e1

> FDA 483_RESPONSE for Wedgewood Connect, LLC on November 17, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483_RESPONSE
- Company Name: Wedgewood Connect, LLC
- Inspection Date: 2023-11-17
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations Division I

## Related Documents

- [145 - 2018-05-29](https://www.globalkeysolutions.net/records/145/wedgewood-connect-llc/44a77771-dde4-46ed-bcd3-26323f1114bc)
- [483 - 2014-10-07](https://www.globalkeysolutions.net/records/483/wedgewood-connect-llc/7050c50b-8e1d-4f8f-8990-787483ea4114)
- [483 - 2018-12-19](https://www.globalkeysolutions.net/records/483/wedgewood-connect-llc/9bf23e25-2dd6-4f6f-8404-6b1b89d277ae)
- [UNTITLED_LETTER - 2023-11-17](https://www.globalkeysolutions.net/records/untitled_letter/wedgewood-connect-llc/48ee4659-fbc1-4f3a-bac8-182cf65c19f4)
- [483_RESPONSE - 2013-11-05](https://www.globalkeysolutions.net/records/483_response/wedgewood-connect-llc/b0058e4a-0101-4dd3-92f7-b03a4d0a6e07)

## Related Officers

- [Program Division Director](https://www.globalkeysolutions.net/people/steven-e-porter/5448db0e-32f0-4e98-8a5f-9f0857373b06)
- [Regulatory Affairs Specialist](https://www.globalkeysolutions.net/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [Statistical Science Director](https://www.globalkeysolutions.net/people/anney-lin/e1dc45a5-a28f-4636-be13-e9bee6f3bc4e)
- [Shruti Rao Shreehari](https://www.globalkeysolutions.net/people/shruti-rao-shreehari/fecaf77c-1649-41f2-b8d6-5dcdeb4f59e6)

Company: https://www.globalkeysolutions.net/companies/wedgewood-connect-llc/26eedeaf-d44e-48a5-b4c3-8b28c9b361ff

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations-division-i/798d6a62-d1f1-4f7c-8de3-465e277c13da